Literature DB >> 11819588

Management of difficult inflammatory bowel disease: where are we now?

DS Rampton.   

Abstract

Entities:  

Year:  2000        PMID: 11819588      PMCID: PMC4688742          DOI: 10.3748/wjg.v6.i3.315

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  45 in total

1.  Cyclosporin for severe ulcerative colitis: a user's guide.

Authors:  A Kornbluth; D H Present; S Lichtiger; S Hanauer
Journal:  Am J Gastroenterol       Date:  1997-09       Impact factor: 10.864

Review 2.  Management of Crohn's disease in adults.

Authors:  S B Hanauer; S Meyers
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

Review 3.  The modern medical management of acute, severe ulcerative colitis.

Authors:  J F Marion; D H Present
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-09       Impact factor: 2.566

4.  Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Authors:  W R Connell; M A Kamm; J K Ritchie; J E Lennard-Jones
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

5.  Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

Authors:  Y Bouhnik; M Lémann; J Y Mary; G Scemama; R Taï; C Matuchansky; R Modigliani; J C Rambaud
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

6.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Authors:  W R Connell; M A Kamm; M Dickson; A M Balkwill; J K Ritchie; J E Lennard-Jones
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321

7.  Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: a prospective longterm analysis.

Authors:  H Couckuyt; A M Gevers; G Coremans; M Hiele; P Rutgeerts
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

8.  European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group.

Authors:  E F Stange; R Modigliani; A S Peña; A J Wood; G Feutren; P R Smith
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

9.  A comparison of budesonide with prednisolone for active Crohn's disease.

Authors:  P Rutgeerts; R Löfberg; H Malchow; C Lamers; G Olaison; D Jewell; A Danielsson; H Goebell; O O Thomsen; H Lorenz-Meyer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

10.  Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

Authors:  R C Evans; V S Wong; A I Morris; J M Rhodes
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171

View more
  5 in total

Review 1.  An analysis of 10218 ulcerative colitis cases in China.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Biomechanical Properties of Strictures in Crohn's Disease: Can Dynamic Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography Predict Stiffness?

Authors:  Rune Wilkens; Dong-Hua Liao; Hans Gregersen; Henning Glerup; David A Peters; Charlotte Buchard; Anders Tøttrup; Klaus Krogh
Journal:  Diagnostics (Basel)       Date:  2022-06-02

3.  Effects of probiotic on intestinal mucosa of patients with ulcerative colitis.

Authors:  Hai-Hong Cui; Cun-Long Chen; Ji-De Wang; Yu-Jie Yang; Yong Cun; Jin-Bao Wu; Yu-Hu Liu; Han-Lei Dan; Yan-Ting Jian; Xue-Qing Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

4.  Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats.

Authors:  Wei-Guo Dong; Shao-Ping Liu; Bao-Ping Yu; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

5.  Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis.

Authors:  Wei-Guo Dong; Shao-Ping Liu; Hai-Hang Zhu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.